Abstract:This work developed a biohybrid bacterial system through genetic engineering and biomaterial hybridization in which CDH17 nanobodies are engineered onto the bacteria for tumor targeting and a photothermal material croconium (CR) dye is conjugated on bacteria for PTT induction. When combined with checkpoint blockade CD47 nanobody, the biohybrid bacteria successfully eradicated the tumors through STING activation, and considerably extended survival of the mice. Bacteria can be utilized for cancer therapy owing to their preferential colonization at tumor sites. However, unmodified non‐pathogenic bacteria carry potential risks due to their non‐specific targeting effects, and their anti‐tumor activity is limited when used as monotherapy. In this study, a biohybrid‐engineered bacterial system comprising non‐pathogenic MG1655 bacteria modified with CDH17 nanobodies on their surface and conjugated with photosensitizer croconium (CR) molecules is developed. The resultant biohybrid bacteria can efficiently home to CDH17‐positive tumors, including gastric, pancreatic, and colorectal cancers, and significantly suppress tumor growth upon irradiation. More importantly, biohybrid bacteria‐mediated photothermal therapy (PTT) induced abundant macrophage infiltration in a syngeneic murine colorectal model. Further, that the STING pathway is activated in tumor macrophages by the released bacterial nucleic acid after PTT is revealed, leading to the production of type I interferons. The addition of CD47 nanobody but not PD‐1 antibody to the PTT regimen can eradicate the tumors and extend survival. This results indicate that bacteria endowed with tumor‐specific selectivity and coupled with photothermal payloads can serve as an innovative strategy for low‐immunogenicity cancers. This strategy can potentially reprogram the tumor microenvironment by inducing macrophage infiltration and enhancing the efficacy of immunotherapy targeting macrophages.

Engineered bacteria detect tumor DNA

Programmable probiotics for detection of cancer in urine

Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection

Engineered immune cells as highly sensitive cancer diagnostics

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Self-adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity

Sonogenetics-controlled Synthetic Designer Cells for Cancer Therapy in Tumor Mouse Models

Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

Engineered skin bacteria induce antitumor T cell responses against melanoma

A discovery platform to identify inducible synthetic circuitry from varied microbial sources

Ultrasensitive Detection of Circulating Tumor DNA of Lung Cancer Via an Enzymatically Amplified SERS-Based Frequency Shift Assay

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field

Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer

Engineered Leukocyte Biomimetic Colorimetric Sensor Enables High-Efficient Detection of Tumor Cells Based on Bioorthogonal Chemistry.

Programmable Bacteria‐Based Biohybrids As Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Engineered live bacteria as disease detection and diagnosis tools

Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy

Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity